Plus Therapeutics shares owned by Vanguard Group
Quarter-by-quarter ownership of Plus Therapeutics (PSTV) shares owned by Vanguard Group
from 13F filings
Historical chart of Vanguard Group investment in Plus Therapeutics
Tip: Access up to 7 years of quarterly data
All positions including Plus Therapeutics held by Vanguard Group consolidated in one spreadsheet with up to 7 years of data
Download as csv
Download as Excel
Quarterly reported holdings in Plus Therapeutics by Vanguard Group
| Quarter filed | Position value | Share count | Share price at filing |
|---|---|---|---|
| 2025-12-31 | $1.2M | 2.3M | 0.51 |
| 2025-09-30 | $990k | 1.4M | 0.68 |
| 2025-06-30 | $11k | 33k | 0.35 |
| 2025-03-31 | $31k | 33k | 0.95 |
| 2024-12-31 | $37k | 33k | 1.15 |
| 2024-09-30 | $48k | 33k | 1.46 |
| 2024-06-30 | $48k | 33k | 1.47 |
| 2024-03-31 | $59k | 33k | 1.81 |
| 2023-12-31 | $57k | 33k | 1.75 |
| 2023-09-30 | $22k | 16k | 1.34 |
| 2023-06-30 | $147k | 73k | 2.02 |